Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 2
1987 4
1989 2
1990 3
1991 4
1992 2
1996 2
1997 2
1999 7
2000 5
2001 7
2002 6
2003 5
2004 8
2005 7
2006 5
2007 6
2008 4
2009 6
2010 7
2011 6
2012 4
2013 4
2014 8
2015 9
2016 13
2017 13
2018 11
2019 11
2020 12
2021 9
2022 17
2023 15
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean dft and cardiovascular diseases (563 results)?
Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
Wu YW, Comstock BA, Gonzalez FF, Mayock DE, Goodman AM, Maitre NL, Chang T, Van Meurs KP, Lampland AL, Bendel-Stenzel E, Mathur AM, Wu TW, Riley D, Mietzsch U, Chalak L, Flibotte J, Weitkamp JH, Ahmad KA, Yanowitz TD, Baserga M, Poindexter BB, Rogers EE, Lowe JR, Kuban KCK, O'Shea TM, Wisnowski JL, McKinstry RC, Bluml S, Bonifacio S, Benninger KL, Rao R, Smyser CD, Sokol GM, Merhar S, Schreiber MD, Glass HC, Heagerty PJ, Juul SE; HEAL Consortium. Wu YW, et al. N Engl J Med. 2022 Jul 14;387(2):148-159. doi: 10.1056/NEJMoa2119660. N Engl J Med. 2022. PMID: 35830641 Free PMC article. Clinical Trial.
Uromodulin in mineral metabolism.
Wolf MTF, Zhang J, Nie M. Wolf MTF, et al. Curr Opin Nephrol Hypertens. 2019 Sep;28(5):481-489. doi: 10.1097/MNH.0000000000000522. Curr Opin Nephrol Hypertens. 2019. PMID: 31205055 Free PMC article. Review.
RECENT FINDINGS: UMOD is mostly secreted in the thick ascending limb (TAL) and to a lesser degree in the distal convoluted tubule (DCT). UMOD secretion is regulated by the calcium-sensing receptor. ...Higher serum UMOD has also been linked to a lower risk of cardiovascu
RECENT FINDINGS: UMOD is mostly secreted in the thick ascending limb (TAL) and to a lesser degree in the distal convoluted tubule (DCT
Regulation of the WNK4-SPAK-NCC pathway by the calcium-sensing receptor.
Chávez-Canales M, García JA, Gamba G. Chávez-Canales M, et al. Curr Opin Nephrol Hypertens. 2023 Sep 1;32(5):451-457. doi: 10.1097/MNH.0000000000000915. Epub 2023 Jul 7. Curr Opin Nephrol Hypertens. 2023. PMID: 37530086 Review.
RECENT FINDINGS: The activation of CaSR in TALH cells during hypercalcemia inhibits NKCC2 and ROMK activity, reducing paracellular Ca2+ reabsorption but decreasing salt reabsorption. This pathway enables NaCl reabsorption in the DCT while promoting Ca2+ excretion. CaSR act …
RECENT FINDINGS: The activation of CaSR in TALH cells during hypercalcemia inhibits NKCC2 and ROMK activity, reducing paracellular Ca2+ reab …
Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.
Tong DC, Quinn S, Nasis A, Hiew C, Roberts-Thomson P, Adams H, Sriamareswaran R, Htun NM, Wilson W, Stub D, van Gaal W, Howes L, Collins N, Yong A, Bhindi R, Whitbourn R, Lee A, Hengel C, Asrress K, Freeman M, Amerena J, Wilson A, Layland J. Tong DC, et al. Circulation. 2020 Nov 17;142(20):1890-1900. doi: 10.1161/CIRCULATIONAHA.120.050771. Epub 2020 Aug 29. Circulation. 2020. PMID: 32862667 Clinical Trial.
Colchicine, a commonly used treatment for gout, has recently emerged as a novel therapeutic option in cardiovascular medicine owing to its anti-inflammatory properties. We sought to determine the potential usefulness of colchicine treatment in patients with ACS. ...CONCLUS …
Colchicine, a commonly used treatment for gout, has recently emerged as a novel therapeutic option in cardiovascular medicine owing t …
SATB1 and PTEN expression patterns in biopsy proven kidney diseases.
Borić Škaro D, Filipović N, Mizdrak M, Glavina Durdov M, Šolić I, Kosović I, Lozić M, Racetin A, Jurić M, Ljutić D, Vukojević K. Borić Škaro D, et al. Acta Histochem. 2020 Dec;122(8):151631. doi: 10.1016/j.acthis.2020.151631. Epub 2020 Nov 2. Acta Histochem. 2020. PMID: 33152540
There were 19 samples in proliferative and 13 samples in non- proliferative group of renal diseases. As control group, 9 specimens of healthy kidney tissue taken after surgery of kidney tumour were used. ...RESULTS: Both markers were positive in all investigated kidney str …
There were 19 samples in proliferative and 13 samples in non- proliferative group of renal diseases. As control group, 9 specimens of …
Transcranial Direct-Current Stimulation in Subacute Aphasia: A Randomized Controlled Trial.
Stockbridge MD, Elm J, Breining BL, Tippett DC, Sebastian R, Cassarly C, Teklehaimanot A, Spell LA, Sheppard SM, Vitti E, Ruch K, Goldberg EB, Kelly C, Keator LM, Fridriksson J, Hillis AE. Stockbridge MD, et al. Stroke. 2023 Apr;54(4):912-920. doi: 10.1161/STROKEAHA.122.041557. Epub 2023 Mar 13. Stroke. 2023. PMID: 36912144 Free PMC article. Clinical Trial.
Kir4.1 deletion prevents salt-sensitive hypertension in early streptozotocin-induced diabetic mice via Na + -Cl - cotransporter in the distal convoluted tubule.
Gao ZX, Wei QC, Shu TT, Li ST, Zhou R, Li MY, Mao ZH, Liu DW, Liu ZS, Wu P. Gao ZX, et al. J Hypertens. 2023 Jun 1;41(6):958-970. doi: 10.1097/HJH.0000000000003419. Epub 2023 Apr 4. J Hypertens. 2023. PMID: 37016934
Compared to the vehicle, STZ mice showed increased Kir4.1 expression and activity in the DCT, a more negative membrane potential, higher NCC abundance, and enhanced hydrochlorothiazide-induced natriuretic effect. However, HS had no significant effect on basolateral Kir4.1 …
Compared to the vehicle, STZ mice showed increased Kir4.1 expression and activity in the DCT, a more negative membrane potential, hig …
Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes.
Julla JB, Girard D, Diedisheim M, Saulnier PJ, Tran Vuong B, Blériot C, Carcarino E, De Keizer J, Orliaguet L, Nemazanyy I, Potier C, Khider K, Tonui DC, Ejlalmanesh T, Ballaire R, Mambu Mambueni H, Germain S, Gaborit B, Vidal-Trécan T, Riveline JP, Garchon HJ, Fenaille F, Lemoine S, Carlier A, Castelli F, Potier L, Masson D, Roussel R, Vandiedonck C, Hadjadj S, Alzaid F, Gautier JF, Venteclef N. Julla JB, et al. Circ Res. 2024 Jan 19;134(2):189-202. doi: 10.1161/CIRCRESAHA.123.322757. Epub 2023 Dec 28. Circ Res. 2024. PMID: 38152893 Free article.
BACKGROUND: Diabetes is a major risk factor for atherosclerotic cardiovascular diseases with a 2-fold higher risk of cardiovascular events in people with diabetes compared with those without. ...METHODS: We investigated the relationship between circulating mo …
BACKGROUND: Diabetes is a major risk factor for atherosclerotic cardiovascular diseases with a 2-fold higher risk of cardio
Kidney Is Essential for Blood Pressure Modulation by Dietary Potassium.
Su XT, Yang CL, Ellison DH. Su XT, et al. Curr Cardiol Rep. 2020 Aug 13;22(10):124. doi: 10.1007/s11886-020-01359-1. Curr Cardiol Rep. 2020. PMID: 32789612 Free PMC article. Review.
Eating more potassium may reduce blood pressure and the occurrence of other cardiovascular diseases by actions on various systems, including the vasculature, the sympathetic nervous system, systemic metabolism, and body fluid volume. ...High-potassium diet targets N …
Eating more potassium may reduce blood pressure and the occurrence of other cardiovascular diseases by actions on various syst …
Molecular mechanisms for the modulation of blood pressure and potassium homeostasis by the distal convoluted tubule.
Castañeda-Bueno M, Ellison DH, Gamba G. Castañeda-Bueno M, et al. EMBO Mol Med. 2022 Feb 7;14(2):e14273. doi: 10.15252/emmm.202114273. Epub 2021 Dec 20. EMBO Mol Med. 2022. PMID: 34927382 Free PMC article. Review.
This phenomenon is explained, at least in part, by the interaction between salt reabsorption in the distal convoluted tubule (DCT) and potassium secretion in the connecting tubule/collecting duct of the mammalian nephron: In order to achieve adequate K(+) secretion levels …
This phenomenon is explained, at least in part, by the interaction between salt reabsorption in the distal convoluted tubule (DCT) an …
200 results